Literature DB >> 435362

Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls.

A Rimsten, H O Adami, B Wahren, B Nordin.   

Abstract

A series of consecutive unselected patients with primary breast carcinoma and their age-matched controls were studied for serum CEA in relation to clinical findings. Raised CEA was found in a similar frequency in patients with primary breast cancer (pre- and postoperative) and in the control women: 16%, 11% and 11%, respectively, exceeded the selected upper limit of the reference range (13 ng/ml) with a double-antibody radioimmunoassay. In the breast-cancer patients, however, 48% of the raised CEA levels exceeded 16 ng/ml, compared with only 20% in the controls. Significant correlations (r approximately 0.3) were found between CEA levels and tumour size, TNM classification and a combined clinical and histopathological classification. A high frequency of raised CEA values in the advanced breast-cancer patients was the essential contribution to these positive correlations. A correlation coefficient of 0.6 was found between pre- and postoperative CEA values. The frequency of smoking and/or chronic disease was unexpectedly high in patients as well as in controls with high CEA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 435362      PMCID: PMC2009851          DOI: 10.1038/bjc.1979.20

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Significance of CEA determinations in patients with cancer of the colon-rectum and the mammary gland in comparison to physiological states in connection with pregnancy.

Authors:  R Lamerz; H Ruider
Journal:  Bull Cancer       Date:  1976 Oct-Dec       Impact factor: 1.276

2.  Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.

Authors:  D C Tormey; T P Waalkes; J J Snyder; R M Simon
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.

Authors:  A M Steward; D Nixon; N Zamcheck; A Aisenberg
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

4.  Evaluation of carcinoembryonic antigen in human mammary carcinoma.

Authors:  T M Chu; T Nemoto
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

5.  Immunology and colonic cancer: further evaluation of the radioimmunoassay for carcinoembryonic antigen of the human digestive system as an adjunct in cancer diagnosis.

Authors:  P Gold; T Wilson; R Romero; J Shuster; S O Freedman
Journal:  Dis Colon Rectum       Date:  1973 Sep-Oct       Impact factor: 4.585

6.  Radioimmunoassay of carcinoembryonic antigen and clinical significance of its level in plasma.

Authors:  S Onizawa; S Watanabe; T Yagura; M Yasutomi; Y Yamamura
Journal:  Gan       Date:  1976-06

7.  A method for estimating bias introduced into epidemiological investigations by those who refuse to participate.

Authors:  H O Adami; J Vegelius
Journal:  Ann Clin Res       Date:  1978-02

8.  Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma.

Authors:  B Wahren; E Lidbrink; A Wallgren; P Eneroth; J Zajicek
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

9.  Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer.

Authors:  H J Hansen; J J Snyder; E Miller; J P Vandevoorde; O N Miller; L R Hines; J J Burns
Journal:  Hum Pathol       Date:  1974-03       Impact factor: 3.466

10.  Carcinoembryonic antigen (CEA) in patients with breast cancer.

Authors:  N M Borthwick; D W Wilson; P A Bell
Journal:  Eur J Cancer       Date:  1977-02       Impact factor: 9.162

View more
  2 in total

1.  Prospective assessment of the role of five tumour markers in breast cancer.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; J Pearson; R W Blamey; A Howell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  Usefulness of traditional serum biomarkers for management of breast cancer patients.

Authors:  Peppino Mirabelli; Mariarosaria Incoronato
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.